BALSALAZIDE

FDA Drug Profile

Drug Details

Generic Name
BALSALAZIDE
Brand Names
N/A
Application Number
Sponsor
Signa S.A. de C.V.
NDC Codes
1
Dosage Forms
POWDER
Routes
N/A
Active Ingredients
BALSALAZIDE DISODIUM

Indications and Usage

1 INDICATIONS AND USAGE Balsalazide disodium capsules are indicated for the treatment of mildly to moderately active ulcerative colitis in patients 5 years of age and older. Limitations of Use: Safety and effectiveness of balsalazide disodium capsules beyond 8 weeks in pediatric patients 5 years to 17 years of age and 12 weeks in adults have not been established. Balsalazide disodium capsules are an aminosalicylate indicated for the treatment of mildly to moderately active ulcerative colitis in patients 5 years of age and older. ( 1 ) Limitations of Use: Safety and effectiveness of balsalazide beyond 8 weeks in children (ages 5 to 17 years) and 12 weeks in adults have not been established. ( 1 )